Background/Objectives: Nurses and nursing students are central to HIV prevention and care, but studies of their general HIV-related knowledge, attitudes, and practices use heterogeneous populations, instruments, scoring systems, and thresholds. This review had three objectives: (1) to meta-analyze, separately, the prevalence of study-defined high/good general HIV knowledge, mean general knowledge scores, prevalence of study-defined positive/favorable general attitudes, and mean favorable-attitude scores; (2) to synthesize HIV-related clinical-practice findings narratively when measures were not comparable; and (3) to explore whether pooled knowledge and attitude estimates differed between practicing nurses and nursing students. General outcomes excluded narrowly focused PrEP-, PEP-, stigma-only, and item-level constructs. Methods: PubMed/MEDLINE, Scopus, PsycINFO, and CINAHL Complete were searched for eligible quantitative studies. Four knowledge and attitude outcomes were meta-analyzed in separate random-effects models; practice outcomes were not pooled. Heterogeneity, 95% prediction intervals, leave-one-out influence, possible small-study effects, subgroup differences, and certainty of evidence were assessed. Results: Thirty-four studies were included. The pooled prevalence of high/good HIV-related knowledge was 52.4% (95% CI 30.4–73.5%; I² = 97.5%; 95% prediction interval 3.6–97.0%), and the pooled mean knowledge score was 66.3% of the possible score (95% CI 60.8–71.8%; I² = 99.8%; prediction interval 40.0–92.5%). Positive/favorable attitudes had a pooled prevalence of 41.6% (95% CI 7.3–86.5%; I² = 99.1%; prediction interval 0.0–99.9%), and the pooled mean favorable-attitude score was 48.1% of the possible range (95% CI 41.9–54.2%; I² = 99.7%; prediction interval 21.3–74.8%). Thus, all four meta-analyses showed extreme heterogeneity and wide prediction intervals. Prespecified subgroup tests did not detect nurse-versus-student differences for either knowledge outcome or favorable-attitude prevalence; a higher pooled mean favorable-attitude score among students was observed in one exploratory comparison. Four studies reported non-equivalent practice indicators (16.0–85.3%), which were not pooled. Certainty was very low for all meta-analyzed outcomes. Conclusions: The pooled estimates should be interpreted as descriptive summaries across heterogeneous operationalizations rather than as precise global nursing-workforce benchmarks or common competency thresholds. More standardized measurement, objective assessment of clinical practice, and longitudinal and interventional research are needed.

Introduction.Pregnancy in women living with HIV remains a significant medical challenge: despite advances in therapy, the risk of vertical transmission persists. In Kazakhstan, no systematic cohort exists to evaluate the course and outcomes of pregnancy among HIV-infected women. Objective. To conduct a retrospective cohort analysis of pregnancy and delivery outcomes in HIV-positive women of reproductive age (18–49 years) in Almaty from January 1, 2018, to December 31, 2022, based on the regional HIV registry. Materials and methods. Data were extracted from the National Electronic HIV Registry and medical records from the AIDS Center and antenatal clinics. A dynamic analysis was carried out on the number of pregnancies, timing of antenatal registration, transmission routes, disease stage, viral load and CD4 count, delivery methods, and perinatal outcomes. Statistical analysis included the Shapiro–Wilk test, χ² test, and analysis of variance, with a significance level of p ≤ 0.05, confidence intervals, and effect size calculations. Results. A total of 483 women were included (21.4% of all HIV-positive women of reproductive age). The mean age was 31.4 ± 5.3 years; antenatal registration occurred at approximately 10–13 weeks of gestation. The frequency of pregnancy termination before 12 weeks was 10.2%, and spontaneous miscarriage occurred in 7.3% (p = 0.008). Elective cesarean sections accounted for ~26%, vaginal deliveries 28%, and emergency cesarean sections 15% (p < 0.05). Sexual transmission represented 91.3% of cases. The proportion of women with suppressed viral load increased from 10.5% in 2018 to 79.7% in 2022. Live births accounted for 99.5%, with neonatal pathologies observed in 3.6% of cases. Conclusions. The study demonstrates improved control of HIV therapy and progress in preventing vertical transmission but also highlights declining coverage of ART prophylaxis. Strengthening healthcare support and coordination is recommended to enhance treatment adherence and improve pregnancy outcomes among women with HIV. Введение. Беременность у женщин с ВИЧ остаётся значимой медицинской проблемой: несмотря на достижения в терапии, риск вертикальной передачи остаётся актуальным. В Казахстане отсутствует системная когорта, оценивающая течение и исход беременности у ВИЧ-инфицированных женщин. Цель исследования. Провести ретроспективный когортный анализ течения беременности и родов у ВИЧ-положительных женщин фертильного возраста (18–49 лет) в Алматы в период с 1 янв. 2018 по 31 дек. 2022 года на основе регионального регистра. Материалы и методы. Данные извлечены из Республиканского электронного регистра ВИЧ‑инфицированных лиц и медицинских записей СПИД‑центра и женских консультаций. Описан динамический анализ количества беременностей, сроков постановки на диспансерный учёт, путей передачи, стадии заболевания, вирусной нагрузки и CD4, методов родоразрешения и перинатальных исходов. Статистическая обработка включала тест Шапиро–Уилка, χ², дисперсионный анализ, с уровнем значимости p ≤ 0,05, доверительными интервалами и расчётом эффектов. Результаты. Всего включены 483 женщины (21,4 % всех ВИЧ‑положительных фертильного возраста). Средний возраст – 31,4 ± 5,3 года; срок постановки на учёт – примерно 10–13 недель. Частота прерывания беременности до 12 недель составила 10,2 %, самопроизвольный выкидыш – 7,3 % (p = 0,008). Плановые кесаревы сечения составили около 26 %, роды — 28 %, экстренные — 15 % (p < 0,05). Половой путь передачи — 91,3 %. Доля женщин со сниженной вирусной нагрузкой выросла с 10,5 % до 79,7 % к 2022 году. Живорождений — 99,5 %; патологии — 3,6 %. Выводы. Исследование демонстрирует улучшение контроля над ВИЧ-терапией и успехи в предотвращении вертикальной передачи, но выявляет снижение охвата АРТ‑профилактикой. Рекомендуется усилить поддержку и взаимодействие медицинских служб, чтобы повысить приверженность лечению и улучшить исходы беременностей у женщин с ВИЧ. Кіріспе. ЖИТС-пен өмір сүретін әйелдердің жүктілігі маңызды медициналық мәселе болып қала береді: терапиядағы жетістіктерге қарамастан, вертикалды берілу қаупі әлі де өзекті. Қазақстанда ЖИТС-пен өмір сүретін әйелдердің жүктілік ағымын және оның нәтижелерін бағалайтын жүйелі когорталық...

Background/Objectives: The aim of this study was to systematically synthesize and quantitatively estimate the mean serum 25-hydroxyvitamin D concentrations across populations in Kazakhstan and to examine variations according to age group, health status, and geographic region. In addition, we specifically evaluated healthy subgroups to establish reference estimates that may be useful for future epidemiological surveillance and public health planning. Methods: A systematic review and meta-analysis was conducted in accordance with the PRISMA 2020 guidelines. PubMed, Scopus, ScienceDirect, and Google Scholar were searched through March 2026 without date restrictions. Studies reporting the mean serum vitamin D concentrations among Kazakhstani populations were included. Random-effects meta-analysis was performed in R. Subgroup analyses were conducted by age group, health status, and geographic region. Meta-regression, influence diagnostics, publication bias assessment, JBI risk-of-bias evaluation, and GRADE certainty-of-evidence assessment were performed. Results: Sixteen studies comprising 28 groups and 5771 participants were included. The pooled mean serum 25(OH)D concentration in the overall cohort was 22.3 ng/mL (95% CI: 19.3–25.3), while the healthy cohort demonstrated a slightly higher pooled mean of 24.4 ng/mL (95% CI: 20.3–28.4). Adolescents had the lowest vitamin D levels among all age groups. Significant regional variability was observed, and meta-regression identified male participant proportion as a significant moderator (p = 0.03). Heterogeneity was extremely high across analyses (I² ≈ 99.9%). Conclusions: Mean serum 25(OH)D concentrations were generally within the insufficient range across the included study groups in Kazakhstan, including healthy subgroups. However, because the certainty of evidence was very low and between-study heterogeneity was extreme, the findings should be interpreted cautiously. These results support the need for standardized national surveillance and locally evaluated public health policy considerations, including targeted supplementation for high-risk groups, screening strategies where clinically indicated, and assessment of food fortification options.